首页> 外文期刊>Endothelium: Journal of endothelial cell research >Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
【24h】

Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.

机译:凝血酶下调人类原代内皮细胞中的血栓调节蛋白表达和活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Thrombomodulin (TM) is a cell surface anticoagulant glycoprotein that plays a key role in the protein C pathway. TM expression in endothelial cells may be modulated by a variety of extracellular signals. Most notably, TM has been shown to be downregulated by inflammatory mediators, such as tumor necrosis factor-alpha and lipopolysaccharide. The objective of this study was to determine the effect of thrombin on TM expression and activity. Thrombin resulted in reduced TM in primary cultures of human endothelial cells by approximately 40% at the level of mRNA, protein, and activity. These effects were blocked by the thrombin inhibitor hirudin. These results suggest that activation of the coagulation cascade may result in a positive-feedback loop consisting of thrombin-mediated repression of TM-dependent protein C activation.
机译:血栓调节蛋白(TM)是一种细胞表面抗凝糖蛋白,在C蛋白途径中起关键作用。内皮细胞中的TM表达可以通过多种细胞外信号来调节。最值得注意的是,TM已被炎症介质(例如肿瘤坏死因子-α和脂多糖)下调。这项研究的目的是确定凝血酶对TM表达和活性的影响。凝血酶导致人内皮细胞原代培养物中TM的mRNA,蛋白质和活性水平降低约40%。凝血酶抑制剂水rud素阻止了这些作用。这些结果表明,凝血级联反应的激活可能导致正反馈回路,该回路由凝血酶介导的对TM依赖性蛋白C激活的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号